相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Benzothiazolyl and Benzoxazolyl Hydrazones Function as Zinc Metallochaperones to Reactivate Mutant p53
John A. Gilleran et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
An integrated view of p53 dynamics, function, and reactivation
Ozlem Demir et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2021)
A selective p53 activator and anticancer agent to improve colorectal cancer therapy
Helena Ramos et al.
CELL REPORTS (2021)
SLMP53-1 interacts with wild-type and mutant p53 DNA-binding domain and reactivates multiple hotspot mutations
Ana Sara Gomes et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2020)
Targeting Cavity-Creating p53 Cancer Mutations with Small-Molecule Stabilizers: the Y220X Paradigm
Matthias R. Bauer et al.
ACS CHEMICAL BIOLOGY (2020)
2-[(4-Hydroxybenzyl) Amino] Phenol (HBAP) Restores the Mutated p53 to the Level Similar to That of Wild-Type p53 Protein and Inhibits Breast Cancer Growth in vivo to by Inducing Tumor Cells Apoptosis
Chenxi Xu et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
SLMP53-2 Restores Wild-Type-Like Function to Mutant p53 through Hsp70: Promising Activity in Hepatocellular Carcinoma
Sara Gomes et al.
CANCERS (2019)
A structure-guided molecular chaperone approach for restoring the transcriptional activity of the p53 cancer mutant Y220C
Matthias R. Bauer et al.
FUTURE MEDICINAL CHEMISTRY (2019)
Salvation of the fallen angel: Reactivating mutant p53
Yang Li et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
New inhibitor of the TAp73 interaction with MDM2 and mutant p53 with promising antitumor activity against neuroblastoma
Sara Gomes et al.
CANCER LETTERS (2019)
Simulations of mutant p53 DNA binding domains reveal a novel druggable pocket
Mohan R. Pradhan et al.
NUCLEIC ACIDS RESEARCH (2019)
Regulators of Oncogenic Mutant TP53 Gain of Function
Satomi Yamamoto et al.
CANCERS (2019)
Therapeutic targeting of p53: all mutants are equal, but some mutants are more equal than others
Kanaga Sabapathy et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Chaperoning the guardian of the genome. The two-faced role of molecular chaperones in p53 tumor suppressor action
Bartosz Wawrzynow et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2018)
Aminobenzothiazole derivatives stabilize the thermolabile p53 cancer mutant Y220C and show anticancer activity in p53-Y220C cell lines
Matthias G. J. Baud et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
The Crystal Structure of the R280K Mutant of Human p53 Explains the Loss of DNA Binding
Ana Sara Gomes et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
The curcumin analog HO-3867 selectively kills cancer cells by converting mutant p53 protein to transcriptionally active wildtype p53
Esha Madan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
New therapeutic strategies to treat human cancers expressing mutant p53 proteins
Giovanni Blandino et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
APR-246 reactivates mutant p53 by targeting cysteines 124 and 277
Qiang Zhang et al.
CELL DEATH & DISEASE (2018)
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Spencer L. G. James et al.
LANCET (2018)
Mutant p53 partners in crime
Michael P. Kim et al.
CELL DEATH AND DIFFERENTIATION (2018)
Targeting the Prion-like Aggregation of Mutant p53 to Combat Cancer
Jerson L. Silva et al.
ACCOUNTS OF CHEMICAL RESEARCH (2018)
Targeting mutant p53 for efficient cancer therapy
Vladimir J. N. Bykov et al.
NATURE REVIEWS CANCER (2018)
Targeting mutant p53 in cancer: a long road to precision therapy
Fiamma Mantovani et al.
FEBS JOURNAL (2017)
Structural Evolution and Dynamics of the p53 Proteins
Giovanni Chillemi et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2017)
Mutant p53 in Cancer: Accumulation, Gain-of-Function, and Therapy
Xuetian Yue et al.
JOURNAL OF MOLECULAR BIOLOGY (2017)
Census and evaluation of p53 target genes
M. Fischer
ONCOGENE (2017)
Multisite aggregation of p53 and implications for drug rescue
GuoZhen Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Dynamics of p53: A Master Decider of Cell Fate
Qingyin Luo et al.
GENES (2017)
Mutant p53 stimulates cell invasion through an interaction with Rad21 in human ovarian cancer cells
Ji-Hye Ahn et al.
SCIENTIFIC REPORTS (2017)
Putting p53 in Context
Edward R. Kastenhuber et al.
CELL (2017)
Silencing of CD24 Enhances the PRIMA-1-Induced Restoration of Mutant p53 in Prostate Cancer Cells
Wei Zhang et al.
CLINICAL CANCER RESEARCH (2016)
Reactivation of wild-type and mutant p53 by tryptophanol-derived oxazoloisoindolinone SLMP53-1, a novel anticancer small-molecule
Joana Soares et al.
ONCOTARGET (2016)
The p53 Pathway: Origins, Inactivation in Cancer, and Emerging Therapeutic Approaches
Andreas C. Joerger et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 85 (2016)
A Designed Inhibitor of p53 Aggregation Rescues p53 Tumor Suppression in Ovarian Carcinomas
Alice Soragni et al.
CANCER CELL (2016)
Reactivation of mutant p53 by a dietary-related compound phenethyl isothiocyanate inhibits tumor growth
M. Aggarwal et al.
CELL DEATH AND DIFFERENTIATION (2016)
Histone deacetylase inhibitors suppress mutant p53 transcription via HDAC8/YY1 signals in triple negative breast cancer cells
Zhao-Tong Wang et al.
CELLULAR SIGNALLING (2016)
COTI-2, a new anticancer drug currently under clinical investigation, targets mutant p53 and negatively modulates the PI3K/AKT/mTOR pathway
K. Y. Salim et al.
EUROPEAN JOURNAL OF CANCER (2016)
Design and synthesis of a C7-aryl piperlongumine derivative with potent antimicrotubule and mutant p53-reactivating properties
Surendra R. Punganuru et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
TP53 Variations in Human Cancers: New Lessons from the IARC TP53 Database and Genomics Data
Liacine Bouaoun et al.
HUMAN MUTATION (2016)
A Novel Third Generation Thiosemicarbazone, COTI-2, Is Highly Effective in Killing Head and Neck Squamous Cell Carcinomas (HNSCC) Bearing a Variety of TP53 Mutations
N. L. Silver et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)
DNAJA1 controls the fate of misfolded mutant p53 through the mevalonate pathway
Alejandro Parrales et al.
NATURE CELL BIOLOGY (2016)
2-Sulfonylpyrimidines: Mild alkylating agents with anticancer activity toward p53-compromised cells
Matthias R. Bauer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Cancer therapeutic approach based on conformational stabilization of mutant p53 protein by small peptides
Perry Tal et al.
ONCOTARGET (2016)
COTI-2, a novel small molecule that is active against multiple human cancer cell lines in vitro and in vivo
Kowthar Y. Salim et al.
ONCOTARGET (2016)
Gain of function of mutant p53: R282W on the peak?
Y. Zhang et al.
ONCOGENESIS (2016)
Whole-genome cartography of p53 response elements ranked on transactivation potential
Toma Tebaldi et al.
BMC GENOMICS (2015)
Small-Molecule NSC59984 Restores p53 Pathway Signaling and Antitumor Effects against Colorectal Cancer via p73 Activation and Degradation of Mutant p53
Shengliang Zhang et al.
CANCER RESEARCH (2015)
Small-Molecule Reactivation of Mutant p53 to Wild-Type-like p53 through the p53-Hsp40 Regulatory Axis
Masatsugu Hiraki et al.
CHEMISTRY & BIOLOGY (2015)
Improving survival by exploiting tumour dependence on stabilized mutant p53 for treatment
E. M. Alexandrova et al.
NATURE (2015)
Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer
Shuo Wei et al.
NATURE MEDICINE (2015)
R248Q mutation-Beyond p53-DNA binding
Jeremy W. K. Ng et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2015)
PRIMA-1met (APR-246) inhibits growth of colorectal cancer cells with different p53 status through distinct mechanisms
Xiao-Lan Li et al.
ONCOTARGET (2015)
Targeting Oncogenic Mutant p53 for Cancer Therapy
Alejandro Parrales et al.
FRONTIERS IN ONCOLOGY (2015)
Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
Patricia A. J. Muller et al.
CANCER CELL (2014)
Wild type p53 reactivation: From lab bench to clinic
Galina Selivanova
FEBS LETTERS (2014)
Prion-like aggregation of mutant p53 in cancer
Jerson L. Silva et al.
TRENDS IN BIOCHEMICAL SCIENCES (2014)
Small molecule restoration of wildtype structure and function of mutant p53 using a novel zinc-metallochaperone based mechanism
Xin Yu et al.
ONCOTARGET (2014)
Correction: Noncanonical DNA Motifs as Transactivation Targets by Wild Type and Mutant p53
Jennifer J. Jordan et al.
PLoS Genetics (2014)
Unravelling mechanisms of p53-mediated tumour suppression
Kathryn T. Bieging et al.
NATURE REVIEWS CANCER (2014)
Structures of oncogenic, suppressor and rescued p53 core-domain variants: mechanisms of mutant p53 rescue
Brad D. Wallentine et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2013)
Variability in functional p53 reactivation by PRIMA-1Met/APR-246 in Ewing sarcoma
D. N. T. Aryee et al.
BRITISH JOURNAL OF CANCER (2013)
Degradation of NF-κB, p53 and other regulatory redox-sensitive proteins by thiol-conjugating and -nitrosylating drugs in human tumor cells
Ameya Paranjpe et al.
CARCINOGENESIS (2013)
Chaperone-mediated autophagy degrades mutant p53
Helin Vakifahmetoglu-Norberg et al.
GENES & DEVELOPMENT (2013)
The substitutions G245C and G245D in the Zn2+-binding pocket of the p53 protein result in differences of conformational flexibility of the DNA-binding domain
S. S. Pintus et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2013)
Small molecule induced reactivation of mutant p53 in cancer cells
Xiangrui Liu et al.
NUCLEIC ACIDS RESEARCH (2013)
Structural studies of p53 inactivation by DNA-contact mutations and its rescue by suppressor mutations via alternative protein-DNA interactions
Amir Eldar et al.
NUCLEIC ACIDS RESEARCH (2013)
Computational identification of a transiently open L1/S3 pocket for reactivation of mutant p53
Christopher D. Wassman et al.
NATURE COMMUNICATIONS (2013)
Targeting Mutant p53 by a SIRT1 Activator YK-3-237 Inhibits the Proliferation of Triple-Negative Breast Cancer Cells
Yong Weon Yi et al.
ONCOTARGET (2013)
p53-stabilizing Agent CP-31398 Prevents Growth and Invasion of Urothelial Cancer of the Bladder in Transgenic UPII-SV40T Mice
Venkateshwar Madka et al.
NEOPLASIA (2013)
Mutant p53: one name, many proteins
William A. Freed-Pastor et al.
GENES & DEVELOPMENT (2012)
Surf the Post-translational Modification Network of p53 Regulation
Bo Gu et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2012)
Reactivation of p53 mutants by p53 reactivation and induction of massive apoptosis in thyroid cancer cells
Rosa Linda Messina et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Mutant p53 Aggregates into Prion-like Amyloid Oligomers and Fibrils IMPLICATIONS FOR CANCER
Ana P. D. Ano Bom et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Halogen-Enriched Fragment Libraries as Leads for Drug Rescue of Mutant p53
Rainer Wilcken et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
Distinct Regulatory Mechanisms and Functions for p53-Activated and p53-Repressed DNA Damage Response Genes in Embryonic Stem Cells
Mangmang Li et al.
MOLECULAR CELL (2012)
Structural Effects of the L145Q, V157F, and R282W Cancer-Associated Mutations in the p53 DNA-Binding Core Domain
Sara Calhoun et al.
BIOCHEMISTRY (2011)
SAHA shows preferential cytotoxicity in mutant p53 cancer cells by destabilizing mutant p53 through inhibition of the HDAC6-Hsp90 chaperone axis
D. Li et al.
CELL DEATH AND DIFFERENTIATION (2011)
Mutant p53 Protein Is Targeted by Arsenic for Degradation and Plays a Role in Arsenic-mediated Growth Suppression
Wensheng Yan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Gambogic Acid-Induced Degradation of Mutant p53 is Mediated by Proteasome and Related to CHIP
Jia Wang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2011)
Functional Inactivation of Endogenous MDM2 and CHIP by HSP90 Causes Aberrant Stabilization of Mutant p53 in Human Cancer Cells
Dun Li et al.
MOLECULAR CANCER RESEARCH (2011)
Gain of function of mutant p53 by coaggregation with multiple tumor suppressors
Jie Xu et al.
NATURE CHEMICAL BIOLOGY (2011)
Quaternary structure of the specific p53-DNA complex reveals the mechanism of p53 mutant dominance
Ricardo Aramayo et al.
NUCLEIC ACIDS RESEARCH (2011)
Electron microscopy studies on the quaternary structure of p53 reveal different binding modes for p53 tetramers in complex with DNA
Roberto Melero et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The relevance of protein-protein interactions for p53 function: the CPE contribution
Maria Rosario Fernandez-Fernandez et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2011)
Analysis of the DNA-binding activity of p53 mutants using functional protein microarrays and its relationship to transcriptional activation
Jitka Malcikova et al.
BIOLOGICAL CHEMISTRY (2010)
p53-family proteins and their regulators: hubs and spokes in tumor suppression
L. Collavin et al.
CELL DEATH AND DIFFERENTIATION (2010)
Safe and targeted anticancer efficacy of a novel class of antioxidant-conjugated difluorodiarylidenyl piperidones: Differential cytotoxicity in healthy and cancer cells
Karuppaiyah Selvendiran et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
The Mdm2-p53 relationship evolves: Mdm2 swings both ways as an oncogene and a tumor suppressor
James J. Manfredi
GENES & DEVELOPMENT (2010)
ATP Binding to Hsp90 Is Sufficient for Effective Chaperoning of p53 Protein
Dawid Walerych et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
SCH529074, a Small Molecule Activator of Mutant p53, Which Binds p53 DNA Binding Domain (DBD), Restores Growth-suppressive Function to Mutant p53 and Interrupts HDM2-mediated Ubiquitination of Wild Type p53
Mark Demma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
p53 at a glance
Colleen A. Brady et al.
JOURNAL OF CELL SCIENCE (2010)
Folding of Tetrameric p53: Oligomerization and Tumorigenic Mutations Induce Misfolding and Loss of Function
David J. Lubin et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
Mutant p53 reactivation by PRIMA-1MET induces multiple signaling pathways converging on apoptosis
J. M. R. Lambert et al.
ONCOGENE (2010)
Stabilization of mutant p53 via alkylation of cysteines and effects on DNA binding
Joel L. Kaar et al.
PROTEIN SCIENCE (2010)
The Tumor Suppressor p53: From Structures to Drug Discovery
Andreas C. Joerger et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
The regulation of p53 by phosphorylation: A model for how distinct signals Integrate into the p53 pathway
Nicola J. Maclaine et al.
AGING-US (2009)
PRIMA-1 Reactivates Mutant p53 by Covalent Binding to the Core Domain
Jeremy M. R. Lambert et al.
CANCER CELL (2009)
Blinded by the Light: The Growing Complexity of p53
Karen H. Vousden et al.
CELL (2009)
Modes of p53 Regulation
Jan-Philipp Kruse et al.
CELL (2009)
Structural Basis of Restoring Sequence-Specific DNA Binding and Transactivation to Mutant p53 by Suppressor Mutations
Oded Suad et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
Hsp70 molecular chaperones are required to support p53 tumor suppressor activity under stress conditions
D. Walerych et al.
ONCOGENE (2009)
Multiple conformations of full-length p53 detected with single-molecule fluorescence resonance energy transfer
Fang Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The expanding universe of p53 targets
Daniel Menendez et al.
NATURE REVIEWS CANCER (2009)
When mutants gain new powers: news from the mutant p53 field
Ran Brosh et al.
NATURE REVIEWS CANCER (2009)
Impact of low-frequency hotspot mutation R282Q on the structure of p53 DNA-binding domain as revealed by crystallography at 1.54 Å resolution
Chao Tu et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2008)
Structural biology of the tumor suppressor p53
Andreas C. Joerger et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2008)
A novel p53 rescue compound induces p53-dependent growth arrest and sensitises glioma cells to Apo2L/TRAIL-induced apoptosis
L. Weinmann et al.
CELL DEATH AND DIFFERENTIATION (2008)
Does control of mutant p53 by Mdm2 complicate cancer therapy?
Carol Prives et al.
GENES & DEVELOPMENT (2008)
The inherent instability of mutant p53 is alleviated by Mdm2 or p16INK4a loss
Tamara Terzian et al.
GENES & DEVELOPMENT (2008)
Mutant p53 targeting by the low molecular weight compound STIMA-1
Nicole Zache et al.
MOLECULAR ONCOLOGY (2008)
Transcriptional control of human p53-regulated genes
Todd Riley et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Small-molecule RETRA suppresses mutant p53-bearing cancer cells through a p73-dependent salvage pathway
J. E. Kravchenko et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Structure of tumor suppressor p53 and its intrinsically disordered N-terminal transactivation domain
Mark Wells et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Targeted rescue of a destabilized mutant of p53 by an in silico screened drug
Frank M. Boeckler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Quaternary structures of tumor suppressor p53 and a specific p53-DNA complex
Henning Tidow et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype:: Lessons from recent developments in the IARC TP53 database
Audrey Petitjean et al.
HUMAN MUTATION (2007)
Structure-function-rescue: the diverse nature of common p53 cancer mutants
A. C. Joerger et al.
ONCOGENE (2007)
Structure of the human p53 core domain in the absence of DNA
Ying Wang et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2007)
Discovery and development of SAHA as an anticancer agent
P. A. Marks
ONCOGENE (2007)
Restoration of p53 function leads to tumour regression in vivo
Andrea Ventura et al.
NATURE (2007)
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Wen Xue et al.
NATURE (2007)
Inactive full-length p53 mutants lacking dominant wild-type p53 inhibition highlight loss of heterozygosity as an important aspect of p53 status in human cancers
Lawrence R. Dearth et al.
CARCINOGENESIS (2007)
Effects of oncogenic mutations and DNA response elements on the binding of p53 to p53-binding protein 2 (53BP2)
Henning Tidow et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Structural basis for understanding oncogenic p53 mutations and designing rescue drugs
Andreas C. Joerger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Effects of common cancer mutations on stability and DNA binding of full-length p53 compared with isolated core domains
Hwee Ching Ang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Structure of the p53 core domain dimer bound to DNA
William C. Ho et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Cooperative fluctuations point to the dimerization interface of p53 core domain
Nigar Kantarci et al.
BIOPHYSICAL JOURNAL (2006)
Structural basis of DNA recognition by p53 tetramers
Malka Kitayner et al.
MOLECULAR CELL (2006)
Reactivation of mutant p53 and induction of apoptosis in human tumor cells by maleimide analogs
VJN Bykov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Temporal dissection of p53 function in vitro and in vivo
MA Christophorou et al.
NATURE GENETICS (2005)
PRIMA-1MET synergizes with cisplatin to induce tumor cell apoptosis
VJN Bykov et al.
ONCOGENE (2005)
Structures of p53 cancer mutants and mechanism of rescue by second-site suppressor mutations
AC Joerger et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
A global suppressor motif for p53 cancer mutants
TE Baroni et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Structural distortion of p53 by the mutation R249S and its rescue by a designed peptide:: Implications for Mutant conformation
A Friedler et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
Crystal structure of a superstable mutant of human p53 core domain - Insights into the mechanism of rescuing oncogenic mutations
AC Joerger et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Cooperative binding of tetrameric p53 to DNA
RL Weinberg et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome
GA Lang et al.
CELL (2004)
Rescue of mutants of the tumor suppressor p53 in cancer cells by a designed peptide
N Issaeva et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Rescue of mutant p53 transcription function by ellipticine
YH Peng et al.
ONCOGENE (2003)
Kinetic instability of p53 core domain mutants - Implications for rescue by small molecules
A Friedler et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Phosphorylation and hsp90 binding mediate heat shock stabilization of p53
CG Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Mutant p53-dependent growth suppression distinguishes PRIMA-1 from known anticancer drugs: a statistical analysis of information in the National Cancer Institute database
VJN Bykov et al.
CARCINOGENESIS (2002)
Biogenesis of p53 involves cotranslational dimerization of monomers and posttranslational dimerization of dimers - Implications on the dominant negative effect
CD Nicholls et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Factors governing loss and rescue of DNA binding upon single and double mutations in the p53 core domain
JD Wright et al.
NUCLEIC ACIDS RESEARCH (2002)
Characterization of the p53-rescue drug CP-31398 in vitro and in living cells
TM Rippin et al.
ONCOGENE (2002)
A peptide that binds and stabilizes p53 core domain:: Chaperone strategy for rescue of oncogenic mutants
A Friedler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound
VJN Bykov et al.
NATURE MEDICINE (2002)
Restoration of wild-type conformation and activity of a temperature-sensitive mutant of p53 (p53(V272M)) by the cytoprotective aminothiol WR1065 in the esophageal cancer cell line TE-1
S North et al.
MOLECULAR CARCINOGENESIS (2002)
Quantitative analysis of residual folding and DNA binding in mutant p53 core domain: definition of mutant states for rescue in cancer therapy
AN Bullock et al.
ONCOGENE (2000)
Mechanism of rescue of common p53 cancer mutations by second-site suppressor mutations
PV Nikolova et al.
EMBO JOURNAL (2000)
分享论文
